Morphine given as IPCA

PreclinicalSmall molecule

CCui Xulei

Morphine given as IPCA is one of 90 small molecule programs targeting Chronic pain. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic PainActive, not recruiting

Quadratus Lumborum BlockTerminated

Laparoscopic Renal SurgeryCompleted

Post Operative PainCompleted

Chronic PainPreclinical

Active, not recruiting

Quadratus Lumborum BlockPreclinical

Terminated

Laparoscopic Renal SurgeryPreclinical

Completed

Post Operative PainPreclinical

Completed

Competition

Competitive Landscape

77 competitors in Chronic Pain

#DrugCompanyPhaseTrials

Xylocaine

MMEDRx USA, Inc.

Approved

5 2

MS Contin

HHikma Pharmaceuticals LLC

Approved

4 3

Marinol

Suboxone

3 5

Intuniv

PPromius Pharma, LLC

Approved

2 6

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

2 7

Sufenta

LLeaf Vertical Inc.

Approved

1 8

Pitocin

RRetrophin

Approved

1 9

Bendopa

MMerz North America, Inc.

Mirapex

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Laparoscopic Renal Surgery1 trial

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Completed·CCui Xulei·N/A·NCT02841982·30 enrolled

Post Operative Pain1 trial

TQLB for Postoperative Pain After Laparoscopic Partial Nephrectomy

Completed·CCui Xulei·N/A·NCT03982784·60 enrolled

Chronic pain1 trial

Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision

Completed·CCui Xulei·N/A·NCT02817321·76 enrolled

Quadratus Lumborum Block1 trial

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

Terminated·CCui Xulei·N/A·NCT02914015·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Morphine given as IPCA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Morphine given as IPCA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Morphine given as IPCA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cui Xulei company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCui Xulei

Morphine given as IPCA

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Laparoscopic Renal Surgery1 trial

Post Operative Pain1 trial

Chronic pain1 trial

Quadratus Lumborum Block1 trial

References

Drug Info

Quick Facts

Related News